This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, W.
Right arrow Articles by Freedman, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, W.
Right arrow Articles by Freedman, L. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2000, p. 8008-8017, Vol. 20, No. 21
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Discrete Roles for Peroxisome Proliferator-Activated Receptor gamma  and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators

Wen Yang, Christophe Rachez, and Leonard P. Freedman*

Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Received 2 May 2000/Returned for modification 22 June 2000/Accepted 31 July 2000

Peroxisome proliferator-activated receptor gamma  (PPARgamma ) plays a major role in adipogenesis. PPARgamma binds to DNA as a heterodimer with retinoid X receptor (RXR), and PPARgamma -RXR can be activated by ligands specific for either receptor; the presence of both ligands can result in a cooperative effect on the transactivation of target genes. How these ligands mediate transactivation, however, remains unclear. PPARgamma is known to interact with both the p160/SRC-1 family of coactivators and the distinct, multisubunit coactivator complex called DRIP. A single DRIP subunit, DRIP205 (TRAP220, PBP), binds directly to PPARgamma . Here we report that PPARgamma and RXR selectively interacted with DRIP205 and p160 proteins in a ligand-dependent manner. At physiological concentrations, RXR-specific ligands only induced p160 binding to RXR, and PPARgamma -specific ligands exclusively recruited DRIP205 but not p160 coactivators to PPARgamma . This selectivity was not observed in interaction assays off DNA, implying that the specificity of coactivator binding in response to ligand is strongly influenced by the allosteric effects of DNA-bound heterodimers. These coactivator-selective effects were also observed in transient-transfection assays in the presence of overexpressed p160 or DRIP coactivators. The results suggest that the cooperative effects of PPARgamma - and RXR-specific ligands may occur at the level of selective coactivator recruitment.


* Corresponding author. Mailing address: Cell Biology Program---Box 470, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-2976. Fax: (212) 717-3298. E-mail: l-freedman{at}ski.mskcc.org.


Molecular and Cellular Biology, November 2000, p. 8008-8017, Vol. 20, No. 21
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bugge, A., Grontved, L., Aagaard, M. M., Borup, R., Mandrup, S. (2009). The PPAR{gamma}2 A/B-Domain Plays a Gene-Specific Role in Transactivation and Cofactor Recruitment. Mol. Endocrinol. 23: 794-808 [Abstract] [Full Text]  
  • Ding, N., Tomomori-Sato, C., Sato, S., Conaway, R. C., Conaway, J. W., Boyer, T. G. (2009). MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression. J. Biol. Chem. 284: 2648-2656 [Abstract] [Full Text]  
  • Zapata-Gonzalez, F., Rueda, F., Petriz, J., Domingo, P., Villarroya, F., Diaz-Delfin, J., de Madariaga, M. A., Domingo, J. C. (2008). Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR{gamma}:RXR heterodimers: comparison with other polyunsaturated fatty acids. J. Leukoc. Biol. 84: 1172-1182 [Abstract] [Full Text]  
  • Torra, I. P., Ismaili, N., Feig, J. E., Xu, C.-F., Cavasotto, C., Pancratov, R., Rogatsky, I., Neubert, T. A., Fisher, E. A., Garabedian, M. J. (2008). Phosphorylation of Liver X Receptor {alpha} Selectively Regulates Target Gene Expression in Macrophages. Mol. Cell. Biol. 28: 2626-2636 [Abstract] [Full Text]  
  • Yamazaki, K., Shimizu, M., Okuno, M., Matsushima-Nishiwaki, R., Kanemura, N., Araki, H., Tsurumi, H., Kojima, S., Weinstein, I B., Moriwaki, H. (2007). Synergistic effects of RXR{alpha} and PPAR{gamma} ligands to inhibit growth in human colon cancer cells phosphorylated RXR{alpha} is a critical target for colon cancer management. Gut 56: 1557-1563 [Abstract] [Full Text]  
  • Chou, F.-S., Wang, P.-S., Kulp, S., Pinzone, J. J. (2007). Effects of Thiazolidinediones on Differentiation, Proliferation, and Apoptosis. Mol Cancer Res 5: 523-530 [Abstract] [Full Text]  
  • Zapata-Gonzalez, F., Rueda, F., Petriz, J., Domingo, P., Villarroya, F., de Madariaga, A., Domingo, J. C. (2007). 9-cis-Retinoic Acid (9cRA), a Retinoid X Receptor (RXR) Ligand, Exerts Immunosuppressive Effects on Dendritic Cells by RXR-Dependent Activation: Inhibition of Peroxisome Proliferator-Activated Receptor {gamma} Blocks Some of the 9cRA Activities, and Precludes Them to Mature Phenotype Development. J. Immunol. 178: 6130-6139 [Abstract] [Full Text]  
  • von Knethen, A., Soller, M., Tzieply, N., Weigert, A., Johann, A. M., Jennewein, C., Kohl, R., Brune, B. (2007). PPAR{gamma}1 attenuates cytosol to membrane translocation of PKC{alpha} to desensitize monocytes/macrophages. JCB 176: 681-694 [Abstract] [Full Text]  
  • Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O'Rahilly, S., Palmer, C. N. A., Plutzky, J., Reddy, J. K., Spiegelman, B. M., Staels, B., Wahli, W. (2006). International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. Pharmacol. Rev. 58: 726-741 [Abstract] [Full Text]  
  • Yoo, E. J., Chung, J.-J., Choe, S. S., Kim, K. H., Kim, J. B. (2006). Down-regulation of Histone Deacetylases Stimulates Adipocyte Differentiation. J. Biol. Chem. 281: 6608-6615 [Abstract] [Full Text]  
  • Fukuen, S., Iwaki, M., Yasui, A., Makishima, M., Matsuda, M., Shimomura, I. (2005). Sulfonylurea Agents Exhibit Peroxisome Proliferator-activated Receptor {gamma} Agonistic Activity. J. Biol. Chem. 280: 23653-23659 [Abstract] [Full Text]  
  • Murtaugh, M. A., Ma, K.-n., Caan, B. J., Sweeney, C., Wolff, R., Samowitz, W. S., Potter, J. D., Slattery, M. L. (2005). Interactions of Peroxisome Proliferator-Activated Receptor {gamma} and Diet in Etiology of Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 1224-1229 [Abstract] [Full Text]  
  • Konopleva, M., Elstner, E., McQueen, T. J., Tsao, T., Sudarikov, A., Hu, W., Schober, W. D., Wang, R.-Y., Chism, D., Kornblau, S. M., Younes, A., Collins, S. J., Koeffler, H. P., Andreeff, M. (2004). Peroxisome proliferator-activated receptor {gamma} and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Molecular Cancer Therapeutics 3: 1249-1262 [Abstract] [Full Text]  
  • Malik, S., Guermah, M., Yuan, C.-X., Wu, W., Yamamura, S., Roeder, R. G. (2004). Structural and Functional Organization of TRAP220, the TRAP/Mediator Subunit That Is Targeted by Nuclear Receptors. Mol. Cell. Biol. 24: 8244-8254 [Abstract] [Full Text]  
  • Pineda Torra, I., Freedman, L. P., Garabedian, M. J. (2004). Identification of DRIP205 as a Coactivator for the Farnesoid X Receptor. J. Biol. Chem. 279: 36184-36191 [Abstract] [Full Text]  
  • Sharma, C., Pradeep, A., Wong, L., Rana, A., Rana, B. (2004). Peroxisome Proliferator-activated Receptor {gamma} Activation Can Regulate {beta}-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. J. Biol. Chem. 279: 35583-35594 [Abstract] [Full Text]  
  • Sharma, C., Pradeep, A., Pestell, R. G., Rana, B. (2004). Peroxisome Proliferator-activated Receptor {gamma} Activation Modulates Cyclin D1 Transcription via {beta}-Catenin-independent and cAMP-response Element-binding Protein-dependent Pathways in Mouse Hepatocytes. J. Biol. Chem. 279: 16927-16938 [Abstract] [Full Text]  
  • Landles, C., Chalk, S., Steel, J. H., Rosewell, I., Spencer-Dene, B., Lalani, E.-N., Parker, M. G. (2003). The Thyroid Hormone Receptor-Associated Protein TRAP220 Is Required at Distinct Embryonic Stages in Placental, Cardiac, and Hepatic Development. Mol. Endocrinol. 17: 2418-2435 [Abstract] [Full Text]  
  • Bettoun, D. J., Burris, T. P., Houck, K. A., Buck, D. W. II, Stayrook, K. R., Khalifa, B., Lu, J., Chin, W. W., Nagpal, S. (2003). Retinoid X Receptor Is a Nonsilent Major Contributor to Vitamin D Receptor-Mediated Transcriptional Activation. Mol. Endocrinol. 17: 2320-2328 [Abstract] [Full Text]  
  • Li, X., O'Malley, B. W. (2003). Unfolding the Action of Progesterone Receptors. J. Biol. Chem. 278: 39261-39264 [Full Text]  
  • Gurnell, M., Savage, D. B., Chatterjee, V. K. K., O'Rahilly, S. (2003). The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor {gamma} and Its Therapeutic Modulation. J. Clin. Endocrinol. Metab. 88: 2412-2421 [Abstract] [Full Text]  
  • Liu, J., Li, H., Burstein, S. H., Zurier, R. B., Chen, J. D. (2003). Activation and Binding of Peroxisome Proliferator-Activated Receptor gamma by Synthetic Cannabinoid Ajulemic Acid. Mol. Pharmacol. 63: 983-992 [Abstract] [Full Text]  
  • Koeffler, H. P. (2003). Peroxisome Proliferator-activated Receptor {gamma} and Cancers. Clin. Cancer Res. 9: 1-9 [Abstract] [Full Text]  
  • Schlezinger, J. J., Jensen, B. A., Mann, K. K., Ryu, H.-Y., Sherr, D. H. (2002). Peroxisome Proliferator-Activated Receptor {gamma}-Mediated NF-{kappa}B Activation and Apoptosis in Pre-B Cells. J. Immunol. 169: 6831-6841 [Abstract] [Full Text]  
  • Kluft, C., Kleemann, R., de Maat, M.P.M. (2002). How best to counteract the enemies? By controlling inflammation in the coronary circulation. Eur Heart J Suppl 4: G53-G65 [Abstract]  
  • Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., Jilka, R. L. (2002). Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor-{gamma}2 Ligands on Adipocyte Versus Osteoblast Differentiation. Endocrinology 143: 2376-2384 [Abstract] [Full Text]  
  • Lee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., Chen, J.-L., Li, Y. (2002). T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor gamma , Functions as an Antagonist of Biochemical and Cellular Activities. J. Biol. Chem. 277: 19649-19657 [Abstract] [Full Text]  
  • Delerive, P., De Bosscher, K., Vanden Berghe, W., Fruchart, J.-C., Haegeman, G., Staels, B. (2002). DNA Binding-Independent Induction of I{kappa}B{alpha} Gene Transcription by PPAR{alpha}. Mol. Endocrinol. 16: 1029-1039 [Abstract] [Full Text]  
  • Li, Y., Lazar, M. A. (2002). Differential Gene Regulation by PPAR{gamma} Agonist and Constitutively Active PPAR{gamma}2. Mol. Endocrinol. 16: 1040-1048 [Abstract] [Full Text]  
  • Sewter, C. P., Blows, F., Vidal-Puig, A., O'Rahilly, S. (2002). Regional Differences in the Response of Human Pre-Adipocytes to PPAR{gamma} and RXR{alpha} Agonists. Diabetes 51: 718-723 [Abstract] [Full Text]  
  • Diab, A., Deng, C., Smith, J. D., Hussain, R. Z., Phanavanh, B., Lovett-Racke, A. E., Drew, P. D., Racke, M. K. (2002). Peroxisome Proliferator-Activated Receptor-{gamma} Agonist 15-Deoxy-{Delta}12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis. J. Immunol. 168: 2508-2515 [Abstract] [Full Text]  
  • Mak, H. Y., Parker, M. G. (2001). Use of Suppressor Mutants To Probe the Function of Estrogen Receptor-p160 Coactivator Interactions. Mol. Cell. Biol. 21: 4379-4390 [Abstract] [Full Text]  
  • Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J.-N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K. K., Lazar, M. A., Pestell, R. G. (2001). Inhibition of Cellular Proliferation through I{kappa}B Kinase-Independent and Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Repression of Cyclin D1. Mol. Cell. Biol. 21: 3057-3070 [Abstract] [Full Text]  
  • Warnmark, A., Almlof, T., Leers, J., Gustafsson, J.-A., Treuter, E. (2001). Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERalpha and ERbeta. J. Biol. Chem. 276: 23397-23404 [Abstract] [Full Text]  
  • Schinner, S., Dellas, C., Schroder, M., Heinlein, C. A., Chang, C., Fischer, J., Knepel, W. (2002). Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor gamma through Inhibition of Pax6 Transcriptional Activity. J. Biol. Chem. 277: 1941-1948 [Abstract] [Full Text]